Literature DB >> 30109432

Dysmobility syndrome is associated with prevalent morphometric vertebral fracture in older adults: the Korean Urban-Rural Elderly (KURE) study.

Namki Hong1,2, Chang Oh Kim3, Yoosik Youm4, Jin-Young Choi5, Hyeon Chang Kim6, Yumie Rhee7.   

Abstract

In a community-dwelling elderly cohort, dysmobility syndrome was associated with elevated odds of morphometric vertebral fracture or any prevalent fracture, independent of age and covariates. Dysmobility syndrome improved discrimination for fracture when added to the FRAX score.
INTRODUCTION: Dysmobility syndrome was coined to indicate patients with impaired musculoskeletal health. Data on the association of dysmobility syndrome with prevalent morphometric vertebral fracture (VF) in elderly persons are limited.
METHODS: A total of 1369 community-dwelling elderly subjects (mean age 71.6 years; women 66%) were analyzed. Dysmobility syndrome was defined as ≥ 3 components among falls, low lean mass, high fat mass, osteoporosis, low grip strength, and low timed get-up-and-go performance. VF was defined as a ≥ 25% reduction in the height of vertebral bodies in plain radiographs. Modified cutpoints of each component at which elevate the odds of fracture were investigated using receiver-operating characteristics analysis. Net reclassification improvement (NRI) and integrated discrimination index (IDI) were calculated to assess additive discriminatory value of dysmobility syndrome over FRAX.
RESULTS: The prevalence of VF and any fracture composite of VF and non-VF was 16% and 25%, respectively, increasing according to number of dysmobility components (from 0 to 5; VF 10-35%; any fracture 16-45%). Dysmobility syndrome was associated with elevated odds of VF (adjusted OR [aOR] 1.52, 95% CI 1.08-2.15) or any fracture (aOR 1.46, 95% CI 1.07-1.98) but no longer with non-VF (aOR 1.31, 95% CI 0.86-1.98) in multivariate model, whereas modified definition showed robust association with non-VF (aOR 1.79, 95% CI 1.23-2.60). Dysmobility syndrome improved discrimination for prevalent fracture when added to FRAX (NRI 0.25, 95% CI 0.13-0.37; IDI 0.020, 95% CI 0.014-0.026).
CONCLUSIONS: Dysmobility syndrome was associated with elevated odds of morphometric VF in community-dwelling older adults, independent of age and covariates.

Entities:  

Keywords:  Dysmobility syndrome; Falls; Obesity; Osteoporosis; Sarcopenia

Mesh:

Year:  2018        PMID: 30109432     DOI: 10.1007/s11657-018-0500-2

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  5 in total

1.  The diagnostic value of phase angle, an integrative bioelectrical marker, for identifying individuals with dysmobility syndrome: the Korean Urban-Rural Elderly study.

Authors:  Y W Jung; N Hong; C O Kim; H C Kim; Y Youm; J -Y Choi; Y Rhee
Journal:  Osteoporos Int       Date:  2020-10-30       Impact factor: 4.507

2.  Cohort profile: Korean Urban Rural Elderly (KURE) study, a prospective cohort on ageing and health in Korea.

Authors:  Namki Hong; Kwang-Joon Kim; Su Jin Lee; Chang Oh Kim; Hyeon Chang Kim; Yumie Rhee; Yoosik Youm; Jin-Young Choi; Hyun-Young Park
Journal:  BMJ Open       Date:  2019-10-16       Impact factor: 2.692

3.  The impact of sarcopenia on low back pain and quality of life in patients with osteoporosis.

Authors:  Shoji Iwahashi; Ryuki Hashida; Hiroo Matsuse; Eriko Higashi; Masafumi Bekki; Sohei Iwanaga; Koji Hara; Takahiko Higuchi; Yohei Hirakawa; Asami Kubota; Hiromi Imagawa; Yoko Muta; Kazuhito Minamitani; Tatsuhiro Yoshida; Kimiaki Yokosuka; Kei Yamada; Kimiaki Sato; Naoto Shiba
Journal:  BMC Musculoskelet Disord       Date:  2022-02-11       Impact factor: 2.362

Review 4.  Dysregulated Autophagy Mediates Sarcopenic Obesity and Its Complications via AMPK and PGC1α Signaling Pathways: Potential Involvement of Gut Dysbiosis as a Pathological Link.

Authors:  Ji Yeon Ryu; Hyung Muk Choi; Hyung-In Yang; Kyoung Soo Kim
Journal:  Int J Mol Sci       Date:  2020-09-19       Impact factor: 5.923

5.  Defining an international cut-off of two-legged countermovement jump power for sarcopenia and dysmobility syndrome.

Authors:  N Hong; E Siglinsky; D Krueger; R White; C O Kim; H C Kim; Y Yeom; N Binkley; Y Rhee; B Buehring
Journal:  Osteoporos Int       Date:  2020-09-07       Impact factor: 4.507

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.